Today was the day that Mesoblast and Cynata shareholders found common ground, by way of JB's wall or words, psycho nonsense regarding Hector. That really happened.
For all those Shareholders and other interested parties that were wondering when Lithuania was going to be added to the 'work' done for the FDA P2 trial for GVHD, wonder no longer.....
That's right! Recruiting!
Bam!
Another act of 'progress' whilst the big costs of candidate enrolment and beyond creeps very very slowly. I read somewhere that it's like 'herding cats'.
Has anyone got an appropriate coffee analogy that fits this scenario?
Screenshot(s) from Annual Report of 29 Aug 24, page-25
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.0¢ | 19.0¢ | $19.42K | 101.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8208 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 9829 | 1 |
View Market Depth
| Last trade - 15.42pm 03/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |